David J. Nutt

Foresight brain science, addiction and drugs project
J Psychopharmacol 2005 19: 325. [PDF]  

Philip L. Johnson, Jacob H. Hollis, Rosario Moratalla, Stafford L. Lightman, and Christopher A. Lowry

Acute hypercarbic gas exposure reveals functionally distinct subpopulations of serotonergic neurons in rats
J Psychopharmacol 2005 19: 327-341. [Abstract] [PDF] [References]  

Oscar P. Dall’igna, Adriano B.L. Tort, Diogo O. Souza, and Diogo R. Lara

Cinnarizine has an atypical antipsychotic profile in animal models of psychosis
J Psychopharmacol 2005 19: 342-346. [Abstract] [PDF] [References]  

J. C. Scaife, R. W. Langley, C. M. Bradshaw, and E. Szabadi

Diazepam suppresses the acquisition but not the expression of ‘fearpotentiation’ of the acoustic startle response in man
J Psychopharmacol 2005 19: 347-356. [Abstract] [PDF] [References]  

Jonathon L. Reay, David O. Kennedy, and Andrew B. Scholey

Single doses of Panax ginseng (G115) reduce blood glucose levels and improve cognitive performance during sustained mental activity
J Psychopharmacol 2005 19: 357-365. [Abstract] [PDF] [References]  

Franz X. Vollenweider, Matthias E. Liechti, and Martin P. Paulus

MDMA affects both error-rate dependent and independent aspects of decision-making in a two-choice prediction task
J Psychopharmacol 2005 19: 366-374. [Abstract] [PDF] [References]  

Jeroen A. J. Schmitt, Brenda L. Jorissen, Louise Dye, C. Rob Markus, Nicolaas E.P. Deutz, and Wim J. Riedel

Memory function in women with premenstrual complaints and the effect of serotonergic stimulation by acute administration of an alpha-lactalbumin protein
J Psychopharmacol 2005 19: 375-384. [Abstract] [PDF] [References]  

Abdulla A.-B. Badawy, Christopher J. Morgan, Meirion B. Llewelyn, Selwyn R.J. Albuquerque, and Anne Farmer

Heterogeneity of serum tryptophan concentration and availability to the brain in patients with the chronic fatigue syndrome
J Psychopharmacol 2005 19: 385-391. [Abstract] [PDF] [References]  

Donatella Marazziti, Chiara Pfanner, Bernardo Dell’osso, Antonio Ciapparelli, Silvio Presta, Giorgio Corretti, Elena Di Nasso, Francesco Mungai, and Liliana Dell’osso

Augmentation strategy with olanzapine in resistant obsessive compulsive disorder: an Italian long-term open-label study
J Psychopharmacol 2005 19: 392-394. [Abstract] [PDF] [References]  

Wolfgang Aichhorn, Ulrike Weiss, Josef Marksteiner, Georg Kemmler, Thomas Walch, Gerald Zernig, Renate Stelzig-Schoeler, Christoph Stuppaeck, and Christian Geretsegger

Influence of age and gender on risperidone plasma concentrations
J Psychopharmacol 2005 19: 395-401. [Abstract] [PDF] [References]  

Camilla Haw and Jean Stubbs

A survey of the off-label use of mood stabilizers in a large psychiatric hospital
J Psychopharmacol 2005 19: 402-407. [Abstract] [PDF] [References]  

R. I. Ohlsen and L. S. Pilowsky

The place of partial agonism in psychiatry: recent developments
J Psychopharmacol 2005 19: 408-413. [Abstract] [PDF] [References]  

David Wheatley

Medicinal plants for insomnia: a review of their pharmacology, efficacy and tolerability
J Psychopharmacol 2005 19: 414-421. [Abstract] [PDF] [References]  

Dong-Seon Chungh, Boong-Nyun Kim, and Soo-Churl Cho

Neuroleptic malignant syndrome due to three atypical antipsychotics in a child
J Psychopharmacol 2005 19: 422-425. [Abstract] [PDF] [References]  

Samir Kumar Praharaj, Pankaj Verma, Dipayan Roy, and Anuradha Singh

Is clonidine useful for treatment of clozapine-induced sialorrhea?
J Psychopharmacol 2005 19: 426-428. [Abstract] [PDF] [References]  

Abdulla A.-B. Badawy

Acute tryptophan or tyrosine depletion test: time for reappraisal?
J Psychopharmacol 2005 19: 429-430. [PDF] [References]  

K. E. Lythe, I. M. Anderson, J. F. W. Deakin, R. Elliott, and P. L. Strickland

Reply to Abdulla A.-B. Badawy - Acute tryptophan or tyrosine depletion test: time for reappraisal?
J Psychopharmacol 2005 19: 431. [PDF] [References]  

Serdar Murat Dursun, Jaime Eduardo Cecilio Hallak, Peter Haddad, Adrian Leahy, Anne Byrne, Paul Laurence Strickland, Ian Muir Anderson, Antonio Waldo Zuardi, and John F. William Deakin

Clozapine monotherapy for catatonic schizophrenia: should clozapine be the treatment of choice, with catatonia rather than psychosis as the main therapeutic index?
J Psychopharmacol 2005 19: 432-433. [PDF] [References]  

S. Devarajan and S. M. Dursun

Olanzapine plus venlafaxine in treatment-resistant depression
J Psychopharmacol 2005 19: 434-435. [PDF] [References]  

Dora Kohen

Book Review: Handbook of female psychopharmacology
J Psychopharmacol 2005 19: 436-437. [PDF]  

Dora Kohen

Book Review: Psychotropic Drugs and Women: Fast Facts
J Psychopharmacol 2005 19: 436. [PDF]  

Malcolm Lader

Book Review: Adverse Syndromes and Psychiatric Drugs
J Psychopharmacol 2005 19: 437. [PDF]  

Gavin P. Reynolds

Book Review: Dopamine in the pathophysiology and treatment of schizophrenia - new findings
J Psychopharmacol 2005 19: 438. [PDF]  

To see an article, click its [PDF] link. To add articles to your marked citations, check the boxes to the left of the titles you want, and click the 'Add to Marked Citations' button. To see one abstract at a time, click its [Abstract] link.